Life Sciences
Data from INSERM advance knowledge in life sciences
Published in Cardiovascular Device Liability Week, March 16th, 2008
Investigators publish new data in the report 'CB2 receptors as new therapeutic targets for liver diseases.' "Cannabinoid type-1 (CB1) and type-2 (CB2) receptors belong to the family of G protein-coupled receptors and mediate biological effects of phyto-derived and endogenous cannabinoids. Whereas functions of CB1 receptor have been extensively studied, the CB2 receptor has emerged over the last few years as a critical player in regulation of inflammation, pain, atherosclerosis and osteoporosis," scientists in Creteil, France report.
"Therefore, although still at a preclinical stage, the development of selective CB2 molecules has gained of interest as new targets in drug...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Cancer Vaccines
U.S. Patent Office Upholds Key Human Embryonic Stem Cell Patent - Heart Disease
Researchers at Kyushu University release new data on heart disease - Heart Surgery
Galichia Heart Hospital Lowers Cost of Bypass to $10K - Life Sciences
Reports outline life sciences research from Tehran University of Medical Sciences, Medical Science Center - Abdominal Aortic Aneurysm
Research reports on abdominal aortic aneurysm from D.J. Evers and colleagues provide new insights - Abdominal Aortic Aneurysm
Researchers at Kanazawa University, Division of Pathology target abdominal aortic aneurysm - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
